Youn H Kim
Academic Appointments
- Professor - Med Center Line, Dermatology
- Professor - Med Center Line (By courtesy), Medicine - Oncology
- Member, Cancer Center
Contact Information
-
Clinical Offices
Medical Dermatology 450 Broadway Street Pavilion B, 4th Floor MC 5338 Redwood City, CA 94063 Tel Work (650) 723-6316 Fax (650) 721-3476Cutaneous Oncology 875 Blake Wilbur Dr Clinic A Stanford, CA 94305 Tel Work (650) 723-6316
-
Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Cancer > Cutaneous (Dermatologic) Oncology
- Cutaneous Lymphoma
- Cutaneous Lymphoma - Dermatology
- Dermatology
- Mycosis Fungoides
Administrative Appointments
- Director, Multi-disciplinary Cutaneous Lymphoma Program, Stanford University Medical Center (2004 - present)
- Director, Residency Program, Department of Dermatology, Stanford University Medical Center (2004 - present)
- Medical Director, Photopheresis Unit, Stanford University Medical Center (2004 - present)
Honors and Awards
- Alwin C. Rambar-James B.D. Mark Award for Excellence in Patient Care, Stanford University School of Medicine (2001)
- Distinguished Service Award, Department of Dermatology, Stanford University School of Medicine (1995)
- The Best Doctors in America: Pacific Region, Woodward/White, Inc (1996-)
Professional Education
| Board Certification: | Dermatology, American Board of Dermatology (1989) |
| Residency: | SUMC - Graduate Medical Education, CA (1989) |
| Internship: | Kaiser - San Francisco, (1985) |
| Medical Education: | Stanford University School of Medicine, CA (1984) |
| Doctor of Medicine: | Stanford University, Medicine (1984) |
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Web Site Links
Scientific Focus
Research Interests
Clinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
Clinical Trials
- Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Recruiting
- Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome Recruiting
- Ph II of Single-Agent Enzastaurin for Relapsed Cutaneous T-Cell Lymphoma Recruiting
- Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A Recruiting
- Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-Cell Lymphoma Recruiting
Publications
- Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome. Arch Dermatol. 2009; (6): 667-74
- TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007; (2): 479-84
- Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. Blood. 2007; (11): 4655-62
- Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Am J Surg Pathol. 2009; (4): 591-8
- Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells. Am J Clin Pathol. 2009; (6): 810-9
Trial Administration